Beruflich Dokumente
Kultur Dokumente
Regulation of Osmolality
Inolyn
Contents:
Renal mechanisms for urine concentration
Countercurrent multiplication by the loop of Henle
Action of ADH in the collecting ducts
Feedback control of plasma osmolality
Mechanism of ADH action in the kidney
Failure to concentrate the urine
Differential diagnosis of hypernatremia
Failure to dilute the urine
Differential diagnosis of hyponatremia
Inolyn, 2007
The Urinary System
Inolyn, 2007
Countercurrent multiplication by the
loop of Henle
Loop structure longitudinal gradient of
concentration
Countercurrent: fluid flow – descending
limb () – ascending limb ()
Inolyn, 2007
Properties of the descending and
ascending limbs of a long Henle’s loop
The descending limb
Highly permeable to H2O
Does not actively extrude Na
The ascending limb
Actively transports NaCl out of tubular lumen
into the surrounding interstitial fluid
Impermeable to H2O salt leaves the
tubular fluid without H2O following along
Inolyn, 2007
Mechanism of countercurrent
multiplication
Step 1 - 6
Inolyn, 2007
Vasopressin the basolateral membrane of the tubular
cells (the distal and collecting tubules) through the
circulatory system
Human Physiology, Sherwood, Fig. 14-29, pp. 544 The Renal System, Fig. 3.7; pp. 43
Inolyn, 2007
Mechanism of ADH action in the kidney
Inolyn, 2007
The Renal System, Fig. 3.5 & 3.6; pp. 42
Inolyn, 2007
Feedback control of plasma osmolality
Inolyn, 2007
Vander’s Renal Physiology, Fig. 7-14, pp. 123
Inolyn, 2007
Condition required for urinary
concentration
To concentrate the urine
Adequate solute delivery to the loop of Henle
Normal function of the loop of Henle
ADH release into the circulation
ADH action on the collecting ducts
To dilute the urine
Adequate solute delivery into the loop of Henle and
early distal tubule
Normal function of the loop of Henle and early distal
tubule
No ADH in the circulation
Inolyn, 2007
A case of polyuria
RU, 46-yo man
For several weeks passing large volume of urine (colourless
“like water”) and excessive thirst (drink 5 ls/ more water/ d)
passing similar volume of urine
No history of similar complain, never diagnosed with DM, never
had known kidney disease
He has some ‘emotional problems’ over the years
Family history: unremarkable
Patient: reformed smoke, does not drink alcohol
Examination:
Little agitated- but quite well
Skin, lips, mouth: rather dry
BP: 130/80, pulse: 84 x/’
Urine specimen: very pale colour, glucose (-), blood (-), protein (-)
Inolyn, 2007
What might be causing his polyuria and
thirst?
What determines how concentrated the
urine is under normal condition?
Inolyn, 2007
Failure to concentrate the urine
Mechanism Clinical example
Inolyn, 2007
Differential diagnosis of hyponatremia
Inolyn, 2007
Differential diagnosis of hyponatremia
Management of hyponatremia:
Define the aetiology and reverse the causative
condition
Hypovolaemic states volume replacement and iv
NaCl infusion
Hypervolaemic states Na restriction, water
restriction
SIADH and related condition restriction of water
Hyponatremia no reliable guide to the total
body Na and volume status clinical clues
Inolyn, 2007
The case..
Severe renal impairement excluded (N
plasma Cr, never used loop diuretics)
Hypothalamic DI excluded (plasma ADH level
when patient was dehydrated and hyperosmolar;
cerebral CT scan no structural damage in
hypothalamus/ pituitary fossa)
Patient had been receiving psychiatric treatment
for 1 month (agitated and hypomanic) – Lithium
carbonate 500 mg bd plasma [Li]: 0,9 mmol/l
Inolyn, 2007
The case..
Diagnosis: lithium-induced nephrogenic DI
Result of plasma ADH: high ~ plasma osmolality
Cerebral CT scan: N
Management:
Maintain adequate water intake
If Lithium th/ to be continued close monitoring of plasma Li
level: 0,4-0,8 mmol/ L
If polyuria and thirst persist amiloride (blocks uptake of Li and
Na through the apical cation channel on the cortical collecting
duct)
Inolyn, 2007
Thank You
Clinical features of hypovoalemia &
hypervolaemia
Hypovolaemia Hypervolaemia
Symptoms Thirst Ankle swelling
Dizziness on standing Breathlessness
Confusion
Inolyn, 2007